Rifaximin for the management of colonic diverticular disease: far beyond a simple antibiotic

Affiliations

¹ Gastroenterology Service,ASL BAT, Andria, Italy. antotursi@tiscali.it.
² Clinical Pharmacology and Digestive Pathophysiology Unit, Department of Medicine and Surgery, University of Parma, Italy.
³ Division of Internal Medicine and Gastroenterology, "Cristo Re" Hospital, Rome, Italy.
⁴ Gastroenterology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
⁵ Service of Digestive Diseases, University Clinic Hospital Lozano Blesa, University of Zaragoza, IIS Aragón, Zaragoza, Spain.

Free article

Editorial

Antonio Tursi et al. J Gastrointestin Liver Dis. 2018 Dec.

Free article

. 2018 Dec;27(4):351-355.

doi: 10.15403/jgld.2014.1121.274.rif.

¹ Gastroenterology Service,ASL BAT, Andria, Italy. antotursi@tiscali.it.
² Clinical Pharmacology and Digestive Pathophysiology Unit, Department of Medicine and Surgery, University of Parma, Italy.
³ Division of Internal Medicine and Gastroenterology, "Cristo Re" Hospital, Rome, Italy.
⁴ Gastroenterology Unit, Department of Medicine and Surgery, University of Parma, Parma, Italy.
⁵ Service of Digestive Diseases, University Clinic Hospital Lozano Blesa, University of Zaragoza, IIS Aragón, Zaragoza, Spain.

No abstract available

Publication types